Breaking News
February 19, 2018 - Researchers uncover how excess calcium may influence development of Parkinson’s disease
February 19, 2018 - Psoriasis drug also effective at reducing aortic inflammation
February 19, 2018 - Excess emissions can make serious contributions to air pollution, study shows
February 19, 2018 - Diabetes Drugs Differ on HF; School-Based Obesity Program Flop; Plaque Type in ACS
February 19, 2018 - Surgical infections linked to drug-resistant bugs, study suggests
February 19, 2018 - Poor awareness may hinder a child’s early dental care
February 19, 2018 - FDA Approves Apalutamide (Erleada) to Help Curb a Tough-to-Treat Prostate Cancer
February 19, 2018 - Educational Tool Boosts Cervical Length Screening
February 19, 2018 - Spider’s web inspires removable implant that may control type 1 diabetes
February 19, 2018 - University Hospital of Santiago de Compostela participates in large pancreatic cancer study
February 19, 2018 - New blood test shows promise to revolutionize diagnosis of tick-borne diseases
February 19, 2018 - Report: Use, Not Price, Drives State Health Costs
February 19, 2018 - Emergency services crews often unprepared for diabetic crises
February 19, 2018 - Scientists in Sweden create DNA nanowires that offer hope for treatment of diseases
February 19, 2018 - ID Break: Clean Hands, Fewer Abx; $11 Million HIV Cure?; MenB Vax for Kids
February 19, 2018 - Patient exposure to X-rays depends on how dentists are paid
February 19, 2018 - Study reveals parents’ views toward children’s tanning bed use
February 19, 2018 - Shot may help reduce risk of shingles
February 19, 2018 - FDA approves first treatment to reduce risk of NSCLC progression
February 19, 2018 - FDA Expands Approval of Imfinzi (durvalumab) to Reduce the Risk of Non-Small Cell Lung Cancer Progressing
February 19, 2018 - D.C. Week: Congress Passes Spending Bill
February 19, 2018 - Heart-muscle patches made with human cells improve heart attack recovery
February 19, 2018 - FDA Approves First Blood Test to Detect Concussions
February 19, 2018 - Survival Bump in Bladder Cancer with Keytruda
February 18, 2018 - Scientists describe the mechanism of heart regeneration in the zebrafish
February 18, 2018 - Scientists uncover the structure of microtubule motor proteins
February 18, 2018 - Light-activated cancer drugs without toxic side effects are closer to becoming reality
February 18, 2018 - Pioneering research could provide novel insight into how genomic information is read
February 18, 2018 - Pearls From: David Putrino, PhD
February 18, 2018 - Researchers uncover how cancer stem cells drive triple-negative breast cancer
February 18, 2018 - Morning Break: Anti-Anti-Vaxxers; Private Piercings Prohibited; A Case for Pelvic Massage
February 18, 2018 - Lower-dose radiation effective, safe for HPV+ head and neck cancer after induction chemo
February 18, 2018 - Specialist residential service for adults with autism opens in Swansea
February 18, 2018 - FDA Moves to Limit Loperamide Doses per Package
February 18, 2018 - Alcohol use disorder – Genetics Home Reference
February 18, 2018 - Autism might be better detected using new two-minute questionnaire
February 18, 2018 - Hand hygiene-intervention practices may reduce risk of infection among nursing home patients
February 18, 2018 - Researchers develop most sophisticated mini-livers to date
February 18, 2018 - Obamacare Helped More Young Women Get Prenatal Care: Study
February 18, 2018 - School-Based Program Fails to Dent Kids’ Obesity
February 18, 2018 - Research compares neural activity in children with and without autism spectrum disorder
February 18, 2018 - Poor fitness levels increase the risk dementia, concludes study
February 18, 2018 - Risk Score May Reveal if Kids are Victims of Ill-Treatment
February 18, 2018 - Adding Folic Acid to Corn Masa Flour May Prevent Birth Defects
February 18, 2018 - Acute treatment suppresses posttraumatic arthritis in ankle injury
February 18, 2018 - A Role for Budesonide in Autoimmune Hepatitis?
February 18, 2018 - Lupus patients exhibit altered cell proteins, a discovery with potential implications for diagnostics
February 18, 2018 - Muscle plays vital role in regulating heat loss from the hands
February 18, 2018 - High-tech brain scans can provide new way to define intelligence
February 18, 2018 - Study reveals the association between ultra-processed foods and cancer
February 18, 2018 - Prescription Opioid Use Tied to Higher Pneumonia Risk
February 18, 2018 - A non-invasive method to detect Alzheimer’s disease
February 18, 2018 - Deletion of specific enzyme leads to improvement in memory and cognitive functions
February 18, 2018 - Amyloid protein may be transmitted through neurosurgical instruments, study suggests
February 18, 2018 - Electric brain signals of males and females show differences
February 18, 2018 - American Heart Association commends McDonald’s for offering healthier menu in kids’ meals
February 18, 2018 - Parents Find Kids’ Weight Report Cards Hard to Swallow
February 18, 2018 - Does a Financial Conflict of Interest Ever Expire?
February 18, 2018 - Exercise can improve Alzheimer’s symptoms
February 18, 2018 - Scientists develop green chemistry method to improve pharmaceutical manufacturing efficiency
February 17, 2018 - ‘A Time Clock to a Tissue Clock’ for Acute Stroke Care
February 17, 2018 - Cancer Care Gets Personal | NIH News in Health
February 17, 2018 - Do more youth use or do youth use more?
February 17, 2018 - Eating faster linked to obesity
February 17, 2018 - Who’s Still Smoking? ACS Report Highlights Most Vulnerable Adults
February 17, 2018 - Study of smoking and genetics illuminates complexities of blood pressure
February 17, 2018 - Study reveals new link between bone cells and blood glucose level
February 17, 2018 - Children with reading challenges may have lower than expected binocular vision test results
February 17, 2018 - Mass Shootings Trigger Change for Emergency Medicine
February 17, 2018 - ECMO helps revive woman thought to be drowned
February 17, 2018 - Learning stress-reducing techniques may benefit people with epilepsy
February 17, 2018 - Shedding Pounds Before Weight-Loss Surgery a Smart Move
February 17, 2018 - FDA Approves New Cystic Fibrosis Drug Combo
February 17, 2018 - Augmented Reality helps surgeons to ‘see through’ tissue and reconnect blood vessels
February 17, 2018 - Emotional state affects operation of the entire brain instead of being restricted to specific regions
February 17, 2018 - Apalutamide Slows Metastasis in Prostate Cancer
February 17, 2018 - Kids’ well visits linked to lower appendicitis complications
February 17, 2018 - New NK cell-based immunotherapy effective against several types of leukemia
February 17, 2018 - Producing Super-Swelled Lyotropic Crystals for Drug Development
February 17, 2018 - Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842, an oral JAK1 Inhibitor, for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis
Elderly UC Patients Do Well with Extended-release Budesonide

Elderly UC Patients Do Well with Extended-release Budesonide

image_pdfDownload PDFimage_print

LAS VEGAS — Older patients diagnosed with ulcerative colitis appear have a safety and tolerability profile similar to that of younger counterparts when treated with extended-release budesonide tablets (Uceris), a post hoc analysis of a randomized clinical trial reveals, researchers reported here.

In the study presented at the Crohn’s & Colitis Congress, the team stratified patients by those age 60 or younger and older than 60 and found that ulcerative colitis exacerbations occurred in 15.8% of the younger group receiving a 6 mg daily dose of budesonide, compared with 21.9% of the older patients; among patients taking the higher daily dose of 9 mg, 13.6% of the younger patients had exacerbations, compared with 5.6% of the older patients; and the exacerbation rates for patients taking placebo were 13.8% and 14.7% for the younger and older groups, respectively.

“That basically shows there is no major difference by age group,” said Gary Lichtenstein, MD, director of the Inflammatory Bowel Disease Center at the University of Pennsylvania in Philadelphia, who reported the results in a poster presentation. “What we showed with this analysis is that with this drug, one-size does fit all.”

The pattern was similar for the other major adverse events — headache and nausea — although the outcomes could have been influenced because there were few patients older than 60 in two studies of extended-release budesonide, he noted. A total of 254 patients were assigned to receive the 6 mg dose, 255 were assigned to the 9 mg dose, and 258 were assigned to receive placebo. Of the patients over 60, a total of 32 were assigned to 6 mg budesonide; 18, to 9 mg budesonide; and 34, to placebo.

“We also found no differences in safety concerns when we looked at gender,” Lichtenstein told MedPage Today. Of the 130 men assigned to 6 mg budesonide, 55% had any type of adverse event, and of the 124 women who received the same dose of the drug, 66% had an adverse event. Of the 150 men assigned to receive the 9 mg dose of extended-release budesonide, 55% experienced an adverse event, compared with 58% of of the 105 women assigned to the higher dose. Of the 150 men assigned to placebo, 50% had an adverse event, compared with 58% of the 108 women assigned to placebo in the pooled studies.

The main study determined that 9 mg of extended-release budesonide was effective in inducing remission and promoting mucosal healing among patients with ulcerative colitis. Lichtenstein explained that he and his colleagues conducted the post hoc analysis to try to answer the question of whether the drug maintained its effectiveness as patients age or if there are safety issues in older populations.

The researchers pooled data from two phase III, randomized, double-blind, placebo-controlled studies. Adults diagnosed with mild to moderate ulcerative colitis symptoms for at least 6 months — defined as a score of 4 to 10 on the Ulcerative Colitis Disease Activity Index — received extended-release budesonide at 6 mg, extended-release budesonide at 9 mg, or placebo once daily for up to 8 weeks.

Overall the average age of the patients in the study was about 43, and a little more than 50% of the patients across the studies were men; approximately 70% of the patients where white, 18% Asian, 9% black, and 3% were Hispanic.

Asked for his perspective, Francis Farraye, MD, co-director of the Center for Digestive Disorders at Boston University School of Medicine, who was not involved with the study, told MedPage Today: “Gastroenterologists are hesitant to use steroids in older patients because of the risk of infectious and other complications. This analysis by Dr. Lichtenstein was reassuring in that budesonide use in patients above the age of 60 did not result in an increased rate of complications when contrasted to younger age groups. I would be comfortable using this agent in the appropriate patient for induction of remission in mild-to-moderate ulcerative colitis.”

The study was sponsored by Salix.

Lichtenstein reported financial relationships with Salix, as well as numerous relationships with other pharmaceutical companies either directly or through his institution.

Farraye reported having no relevant relationships with industry.


Tagged with:

About author

Related Articles